title: Evaluation of dalbavancin as chiral selector for HPLC and comparison with teicoplanin-based chiral stationary phases.
abstract: Dalbavancin is a new compound of the macrocyclic glycopeptide family. It was covalently linked to 5 microm silica particles using two different binding chemistries. Approximately 250 racemates including (a) heterocyclic compounds, (b) chiral acids, (c) chiral amines, (d) chiral alcohols, (e) chiral sulfoxides and sulfilimines, (f) amino acids and amino acid derivatives, and (g) other chiral compounds were tested on the two new chiral stationary phases (CSPs) using three different mobile phases. As dalbavancin is structurally related to teicoplanin, the same set of chiral compounds was screened on two commercially available teicoplanin CSPs for comparison. The dalbavancin CSPs were able to separate some enantiomers that were not separated by the teicoplanin CSPs and also showed improved separations for many racemates. However, there were other compounds only separated or better separated on teicoplanin CSPs. Therefore, the dalbavancin CSPs are complementary to the teicoplanin CSPs.
authors.affiliation: Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, Texas 76019-0065, USA.
authors.forename: Xiaotong
authors.initials: X
authors.lastname: Zhang
authors.forename: Ye
authors.initials: Y
authors.lastname: Bao
authors.forename: Ke
authors.initials: K
authors.lastname: Huang
authors.forename: Kimber L
authors.initials: KL
authors.lastname: Barnett-Rundlett
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Armstrong
mesh_terms: D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D017334:Teicoplanin / Q000031:analogs & derivatives* / Q000737:chemistry*
chemical_list: D017334:Teicoplanin; C469289:dalbavancin
references.citation: J Chromatogr A. 2000 Feb 11;869(1-2):111-27
references.pmid: 10720230
references.citation: J Chromatogr A. 1999 Oct 1;857(1-2):145-55
references.pmid: 10536833
references.citation: Chirality. 2004 May 15;16(5):294-301
references.pmid: 15069659
references.citation: Talanta. 1993 Sep;40(9):1367-73
references.pmid: 18965792
references.citation: Chirality. 2004 Nov;16(9):614-24
references.pmid: 15390085
references.citation: Chirality. 2009 Jan;21(1):167-75
references.pmid: 18698639
references.citation: Anal Chem. 2000 Apr 15;72(8):1767-80
references.pmid: 10784140
references.citation: J Chromatogr A. 2000 Nov 3;897(1-2):113-29
references.pmid: 11128195
references.citation: J Chromatogr A. 1995 Jan 13;689(2):285-304
references.pmid: 7874302
references.citation: Drugs. 2008;68(5):639-48; discussion 649-51
references.pmid: 18370443
references.citation: J Chromatogr A. 1996 Apr 19;731(1-2):123-37
references.pmid: 8646327
references.citation: Chirality. 1998;10(7):627-60
references.pmid: 9757575
references.citation: Anal Chem. 1995 Jul 1;67(13):2088-95
references.pmid: 8694248
references.citation: Anal Chem. 1994 May 15;66(10):1690-5
references.pmid: 8030783
references.citation: Expert Rev Anti Infect Ther. 2004 Dec;2(6):845-52
references.pmid: 15566329
references.citation: Pharm Sci Technol Today. 1999 Dec;2(12):484-492
references.pmid: 10603466